Hapvida’s Adjusted Q2 Profit All but Vanishes as Medical Costs Climb

Hapvida's adjusted Q2 2026 profit collapsed 95.8% to R$12.5 million as medical costs outran premiums, even though revenue rose 3.9% to about R$7.97 billion and dental membership grew.